Recent research has found that a new blood test that looks for circulating tumour cells could significantly improve the diagnosis of prostate cancer and avoid unnecessary biopsies and treatments. According to the research by the Queen Mary University of London, combining the new test with prostate-specific antigen (PSA) results can yield a diagnosis of aggressive […]